Category: Vaccine Headlines
Neurologic Events After COVID-19 Vaccines Assessed
MedPageToday All patients hospitalized with new or relapsing neurologic events after SARS-CoV-2 vaccination at a New York tertiary hospital had one or more risk factors for their neurologic condition, a prospective study showed. The most prominent neurologic index events in these vaccinated patients were ischemic stroke (37.7%), encephalopathy (32.6%), seizure (15.9%), and intracranial hemorrhage (ICH; […]
May 30, 2023
Here’s what Pfizer and Moderna say is next for their Covid vaccines
NBC Three years and billions of Covid vaccinations into the pandemic, Pfizer and Moderna say their work is far from over. The two pharmaceutical companies, whose Covid vaccines have become household names, are ushering in a new era for their shots that will elevate the role they play in protecting public health, but also simplify what people need to do to coexist with the virus. […]
May 22, 2023
Safety Data on Maternal RSV Vaccine ‘Favorable,’ FDA Staff Says
MedPageToday A maternal respiratory syncytial virus (RSV) vaccine candidate prevents infections in infants and comes with “generally favorable” safety data, said FDA staff in briefing documents released ahead of an advisory committee meeting this week, but the reviewers “noted potential uncertainty based on the numerical imbalance in premature deliveries.” On Thursday, members of the Vaccines and Related […]
May 16, 2023
Clinical trial of mRNA universal influenza vaccine candidate begins
NIH A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known […]
May 16, 2023
What’s in the RSV vaccine, its side effects and when you can get one
Washington Post The first vaccine to prevent the respiratory disease caused by RSV was approved this week by U.S. regulators for use in adults 60 and older. The shot, developed by pharmaceutical giant GSK, will be rolled out ahead of the fall and winter RSV season, when transmission peaks. Most people are infected by respiratory syncytial virus repeatedly over […]
May 9, 2023
The World’s First RSV Vaccine Just Got Approved in The US
Science Alert For the first time, a vaccine to protect against respiratory syncytial virus (RSV) seems poised to help thousands. The vaccine received approval on May 3 by the US Food and Drug Administration (FDA) for people over 60, and it’s a significant moment that’s been decades in the making. Should it receive approval from the US […]
May 9, 2023
Why Is One Dose Suddenly Enough for the mRNA COVID Vaccines?
MedPageToday The FDA and CDC recently announced that previously unvaccinated Americans can now receive only a single dose of the bivalent Moderna or Pfizer mRNA vaccines. To be clear, this is not saying they can choose to have one or two doses and be considered fully vaccinated either way — only one dose is available to them. […]
May 2, 2023
Vaccine printer could help vaccines reach more people
MIT The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin. Getting vaccines to people who need them isn’t always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don’t have the necessary infrastructure. MIT researchers have come up […]
May 2, 2023
Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says
CNBC The maker of the mpox vaccine is looking at ways to dramatically scale up its production capacity to prepare for a potential threat from smallpox. Bavarian Nordic CEO Paul Chaplin said the rapid spread of mpox last year was a wake-up call for the company, which is based in Denmark. “If it wasn’t mpox but it was smallpox, we are completely at […]
Apr 25, 2023
Advisory Committee on Immunization Practices (ACIP)
CDC Next ACIP Meeting April 19, 2023, 11:00 a.m. – 3:00 p.m. ACIP meetings are virtual. No registration is required to watch the webcasts. Agenda Webcast Link Federal Register
Apr 18, 2023